(Neuro)Cognitive Remediation for Adults With OSIs
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNova Scotia Health Authority
About this trial
(Neuro)Cognitive remediation (CR) is an intervention for people experiencing cognitive impairments that interfere with their daily functioning. Cognition refers to a person's ability to perceive, process, manipulate and respond to information. Attention, memory, abstract reasoning, and processing speed are all examples of cognitive skills. By focusing on improving these underlying skills, the overall aim of cognitive remediation is to improve the participant's daily satisfaction and success. CR can be achieved through teaching compensatory strategies, restoration of cognition through drill and practice and by utilizing regulative metacognitive strategies. Acquired skills and strategies are then 'bridged' or applied to daily functioning with the assistance of the clinician.
This pilot study intends to assess the impacts of a CR program on a population of Military Veterans, police officers, and retirees within the Nova Scotia Operational Stress Injury Clinic (NSOSIC). Researchers believe this program will improve cognitive functioning and that participants will perceive that the program was beneficial.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Clients engaging in treatment at the Nova Scotia OSI Clinic who may benefit from the CR program.
Be experiencing cognitive challenges which may be improved through the cognitive remediation program, as determined by the treating Occupational Therapist.
Disqualifiers
None
Trial design
Design model
Single group
Treatments tested in this trial
(Neuro)Cognitive Remediation
Behavioral(Neuro)Cognitive remediation is an intervention for people experiencing cognitive impairments that interfere with their daily functioning. Attention, memory, abstract reasoning, and processing speed are all examples of cognitive skills. By focusing on improving these underlying skills, the overall aim of cognitive remediation is to improve the client's daily satisfaction and success. Although cognitive remediation programs and strategies have been studied with other populations, it has not been sufficiently evaluated from a mental health trans-diagnostic perspective for military Veterans and police officers and retirees who this research will study.
Treatment groups
20 Participants
are divided into 1 treatment groupGroup A: (Neuro)Cognitive RemediationExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Participant Reported Qualitative Experience
Qualitative data will be obtained through individual semi-structured interviews with all participants of this study. These individual interviews will result in complete transcripts of conversations which can be thoroughly analyzed by researchers. This research will use an interpretive phenomenology framework for analysis, as will be described in the data analysis phase of this document.
Time frame
From enrollment to the end of treatment- up to 17 weeks after enrollment.Secondary outcomes
1
1. Repeatable Battery for the Assessment of Neuropsychological Status Update (RBANS)
A standardized assessment to screen for cognitive functioning which covers 5 domains: Immediate Memory, Visuospatial/Constructional, Language, Attention, and Delayed Memory. Total scale scores can range from 40-160, with lower scores indicating a worse outcome.
Time frame
From enrollment to the end of treatment- up to 17 weeks after enrollment.2
World Health Organization Disability Assessment Schedule 2.0 (WHODAS)
A standardized assessment measuring health and disability across cultures which covers 6 domains: cognition, mobility, self-care, getting along, life activities, and participation. Scores on this measure can range from 0-48, with higher scores representing a worse outcome.
Time frame
From enrollment to the end of treatment- up to 17 weeks after enrollment.3
Patient Health Questionnaire 9 Item (PHQ-9)
A 9-item screening tool used to assess the severity of depression-related symptoms. Scores range from 0-27 with higher scores indicating higher levels of distress.
Time frame
From enrollment to the end of treatment- up to 17 weeks after enrollment.4
Generalized Anxiety Disorder 7 Item (GAD-7)
A 7-item screening tool used to assess the severity of anxiety-related symptoms. Scores range from 0-21 with higher scores indicating higher levels of distress.
Time frame
From enrollment to the end of treatment- up to 17 weeks after enrollment.Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: